Clinical Trial Update: Cynergy: the CYPHER-NEVO Registry

View source ↗

Summary

The CYPHER-NEVO registry study (Cynergy) sponsored by Cordis US Corp. in coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher (sirolimus-eluting coronary stent)
• Nevo

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Status: TERMINATED